CTRI/2025/04/085379尚未招募2/3 期
A Randomized Controlled Clinical Study Of Add On Effect Of Vrikshamla With Shuddha Guggulu In Hyperlipidaemia With Special Reference To Medovriddhi
Dr MRUNALI SHRIRANG BHARATE1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月5日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To study the add on effect of Vrikshamla with Shuddha guggulu on -
研究概览
简要总结
This study is Randomized,Controlled,Clinical, study of add on effect of vrikshmla 500mg bd with guggulu 1gm bd for 30days in pateints of medovridhi with special reference to hyperlipidemia .This study is conducted as PG course at single centre. The primary outcome is to evaluate the effect of vrikshmla on hyperlipidemia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients as per above diagnostic criteria
- •Age between 18 to 60 yrs of either gender.
- •Patients BMI between 25 to 35
- •Patient willing for trial, irrespective of socioeconomic condition.
排除标准
- •Pregnant females and lactating mothers.
- •Subjects suffering from any critical illness that is cardiovascular diseases, renal impairments.
- •Subjects not willing for trial.
- •Patients on Glucocorticoids, statins
- •Patients with uncontrolled diabetes mallitus.
结局指标
主要结局
To study the add on effect of Vrikshamla with Shuddha guggulu on -
时间窗: 30 days
Serum total Cholesterol
时间窗: 30 days
Serum Triglycerides
时间窗: 30 days
Serum High density lipoprotein
时间窗: 30 days
Serum Low Density
时间窗: 30 days
Serum very low density lipoprotein
时间窗: 30 days
次要结局
- To study the add on effect of Vrikshamla with Shuddha guggulu on -(BMI)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
A CLINICAL STUDY TO EVALUATE THE EFFICACY OF VRINDAMADHAVOKTA DASHAMULAADI KASHAYA IN THE MANAGEMENT OF GRIDHRASI WITH SPECIAL REFERENCE TO SCIATICACTRI/2022/07/043799Snehal Navnath Jagtap33
已完成
1 期
Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women VolunteersEmbryo TransferNCT02703181GlaxoSmithKline31
Unknown
4 期
The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and HyperkalemiaType 2 Diabetes Mellitus With Kidney ComplicationsNCT04063930Steno Diabetes Center Copenhagen20
已完成
2 期
A study of Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite (BRAVO).CTRI/2021/11/037901Ophirex Inc110
撤回
3 期
Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management ProgramObesityNCT01387126Canadian Center for Functional Medicine